- PLN32.50m
- PLN26.91m
- PLN29.12m
Annual balance sheet for Genomed SA, fiscal year end - December 31st, PLN millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | |
| Standards: | PAS | PAS | PAS | PAS | — |
| Status: | Final | Final | Final | Final | fx Preliminary |
| Cash | |||||
| Cash and Short Term Investments | 4.92 | 3.49 | 5.26 | 5.24 | — |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1.27 | 1.46 | 1.79 | 1.6 | — |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 8.04 | 8.48 | 10.6 | 9.97 | — |
| Net Property, Plant And Equipment | 2.17 | 1.7 | 1.2 | 2.13 | — |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 10.3 | 10.4 | 12.1 | 12.4 | — |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1.48 | 1.2 | 1.97 | 1.56 | — |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 1.53 | 1.24 | 2.06 | 1.68 | — |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 8.8 | 9.13 | 10.1 | 10.7 | — |
| Total Liabilities & Shareholders' Equity | 10.3 | 10.4 | 12.1 | 12.4 | — |
| Total Common Shares Outstanding |